The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.

"Conflicts of interest Dr. Lang is a co-applicant and receives royalties on patent application WO/2010/046716 entitled ‘Neurological Autoimmune Disorders’. The patent has been licensed to Euroimmun AG for the development of assays for LGI1 and other VGKC-complex antibodies.Dr. Titulaer received research funds for serving on a scientific advisory board of MedImmune LLC., for consultation at Guidepoint Global LLC, and an unrestricted research grant from Euroimmun AG. Erasmus University Medical Center has filed a patent for methods for typing neurological disorders and cancer, and devices for use therein. Dr. Graus received a licensing fee from Euroimmun for the use of IgLON5 as an autoantibody test."

"Funding PG was supported by a fellowship grant from Myaware (UK). MT was supported by a KWF fellowship 2009-4451 by the Dutch Cancer Society."